Data as of Sep 19
| +0.20 / +5.21%|
The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 45.00, with a high estimate of 45.00 and a low estimate of 45.00. The median estimate represents a +1,013.86% increase from the last price of 4.04.
The current consensus among 1 polled investment analysts is to Buy stock in Brainstorm Cell Therapuetics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.